Clinical trials
catalyst calendar across sponsors →Studies where OMDA is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
4 interventional
Held by 13 tracked-famous managers (MILLENNIUM MANAGEMENT LLC, D. E. Shaw & Co., Inc., Point72 Asset Management, L.P., CITADEL ADVISORS LLC, JANE STREET GROUP, LLC, +8 more) · FINRA short interest 5.9 days to cover (settled 2026-07-31) · insider 90d: 0 buys / 18 sells · government filings 180d: none disclosed
| Study | Phase | Status | Interventions | Conditions | Enrollment | Primary completion | Updated |
|---|---|---|---|---|---|---|---|
| Evaluation of a Digital Diabetes Self-Management Education and Support ProgramNCT05368454Change in HbA1cRandomized · Single-masked · Treatment | Not applicable | Completed | Behavioral: Online Diabetes Self-Management Education and Support (DSMES) Program, Standard of Care | Type 2 Diabetes | 100 | 2024-01-24actual | 2024-04-10 |
| Impact of a Digital Self-Management Program on A1C for Individuals With Type 2 DiabetesNCT04892680Change in HbA1c at 6 months from baselineNon-randomized · Single-masked · Treatment | Not applicable | Terminatedsponsor's stated reason: Study terminated prematurely due to operational futility. | Behavioral: Online Diabetes Self-Management Education and Support (DSMES) Program | Type 2 Diabetes | 27 | 2021-08-02actual | 2022-05-11 |
| Preventing Diabetes With Digital Health and CoachingNCT03312764HbA1c reductionRandomized · Double-masked · Prevention | Not applicable | Completed | Behavioral: Online diabetes prevention program, Standard Care | PreDiabetes | 598 | 2020-04-30actual | 2021-02-23 |
| Evaluation of Prevent in Underserved PopulationsNCT02664064% Weight LossNon-randomized · Single-masked · Prevention | Not applicable | Completed | Behavioral: Prevent | Prediabetes, Overweight, Obesity | 227 | Apr 2018actual | 2020-03-04 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19